Market Overview

Global Biopharmaceuticals Market (2018-2025) by Type, Application and Region - A Projected $526 Billion Market -


The "Biopharmaceuticals
Market By Type and Application - Global Opportunity Analysis And
Industry Forecast, 2018-2025"
report has been added to's

The global biopharmaceuticals market accounted for $186,470 million in
2017, and is projected to reach $526,008 million by 2025, registering a
CAGR of 13.8% from 2018 to 2025.

The study provides an in-depth analysis of the global biopharmaceuticals
market along with the current trends and future estimations to elucidate
the imminent investment pockets.

The report presents a quantitative analysis of the market from 2017 to
2025 to enable stakeholders to capitalize on the prevailing market

An extensive analysis of the market based on application assists in
understanding the trends in the industry.

The key market players along with their strategies are thoroughly
analyzed to understand the competitive outlook of the industry.

Market Dynamics


  • Increase in Prevalence of Chronic Diseases
  • Rise in Geriatric Population and Improvement in Healthcare
  • Increase in Strategic Acquisitions and Collaborations


  • High Cost of Drug Development and Threat of Failure
  • Stringent Regulatory Scenario


  • Increase in Purchasing Power of Emerging Economics

Key Players

  • Abbott Laboratories
  • Amgen Inc.
  • Biogen Inc.
  • Eli Lilly and Company
  • F. Hoffmann-La Roche Ltd.
  • Johnson & Johnson
  • Merck & Co. Inc.
  • Novo Nordisk A/S
  • Pfizer Inc.
  • Sanofi

Other Players

  • Bristol Myers Squibb Company
  • Bayer AG
  • Shire PLC

Key Topics Covered

Chapter 1: Introduction

Chapter 2: Executive Summary

Chapter 3: Market Overview

Chapter 4: Biopharmaceuticals Market, by Type

Chapter 5: Biopharmaceuticals Market, by Application

Chapter 6: Biopharmaceuticals Market, by Region

Chapter 7: Company Profiles

For more information about this report visit

View Comments and Join the Discussion!